Isoflucypram: Combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat
| Autor: | Tinwell, H., Bars, R. |
|---|---|
| Zdroj: | In Regulatory Toxicology and Pharmacology June 2022 131 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect